The Long-Term Care Data Cooperative is an NIA-funded research resource that links skilled-nursing records with Medicare and Medicaid claims. For people with mild cognitive impairment, the meaning is stronger future care research and easier trial matching, not a new test or treatment. Mild cognitive impairment means memory problems greater than normal for age, while daily activities remain possible. Risk for Alzheimer's is higher, yet many people do not progress and some return to normal, according to the NIA Alzheimer's Disease Fact Sheet NIA Alzheimer's Disease Fact Sheet.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the cooperative collects
- Why nursing-home data matters for MCI
- What 2026 care research signals
- Practical steps after an MCI diagnosis
What the cooperative collects
The resource is governed by AHCA/NCAL with the IMPACT Collaboratory, Brown, Hebrew SeniorLife and NYU, according to the AHCA/NCAL press release AHCA/NCAL press release. It links skilled-nursing EHR data with Medicare and Medicaid claims for research. That link lets researchers follow health events across clinics, hospitals and long-term care. A Feb. 19, 2026 analysis characterized 2023 residents and facilities against national data, as listed by the IMPACT Collaboratory Publications IMPACT Collaboratory publication listing.
It reported completeness for length of stay and discharge disposition. It also reported completeness for vitals, glucose and medication administration. The NIA 2026 Dementia Care Summit Report describes collection from skilled nursing and assisted living. Stated uses are operations, public-health surveillance, comparative-effectiveness research, and trial recruitment and outcome evaluation. Researcher access is on application.
Why nursing-home data matters for MCI
If you manage memory changes at home, nursing-home records can feel distant. The data still shape the care you may meet later. Hospital visits, medication changes and moves to higher care leave traces in linked claims and EHRs. This resource does not diagnose MCI or predict your course.
It describes facility populations and tests whether key fields are complete enough for study. Complete stay, discharge, vitals and medication data make comparisons more reliable. Better comparisons help families and clinicians learn which care paths reduce harm. They also help trial teams find eligible sites and measure outcomes that matter after diagnosis.
What 2026 care research signals
In a 1,000-person modeled cohort that was 55% MCI and 45% mild dementia, navigator-led collaborative dementia care gained quality-adjusted life years and saved costs versus usual care. It also delivered better value than lecanemab alone, according to Medscape and UCSF reporting Medscape report on collaborative care. Quality-adjusted life years reflect both longer life and better daily health. Savings came alongside better health, not through reduced benefit. Cost pressure makes efficient care urgent. The NIA-funded U.S.
Cost of Dementia Project, reported by the University of Southern California via SciTechDaily, estimated U.S. dementia costs at $818 billion in 2026 using Health and Retirement Study and CMS data. High-value, coordinated support fits that need. Policy is moving the same way. HHS, reported via MedPath Trial, released the 2026 Update to the National Plan on Oct. 22, 2026, replacing six goals with four on risk reduction, innovation, high-value care and family supports. Healthcare News Center reporting adds FDA's Alzheimer's Prevention Accelerator and up to $48.8M in ARPA-H awards for earlier detection and intervention.
Practical steps after an MCI diagnosis
Use the stability of this stage to organize care and information. Good records help every later decision, including whether a study is a fit. Bring a current list of symptoms, drugs and daily changes to each visit.
Share that packet when referrals, home support or facility care arise. Consistent records reduce repeat tests and speed matching when a study seeks people with early-stage changes. Keep the copy where your care partner can find it.
- Ask your clinician what follow-up schedule fits your symptoms
- Keep one current medication, allergy and vitals list
- Track sleep, mood, falls and daily-task changes
- Ask where trial information and caregiver supports are offered locally
- Name a care partner who can attend visits and share updates
You Might Also Like
- NHATS and NSOC Dementia Care Data Priorities in 2026: What the Findings Mean for People With Mild Cognitive Impairment
- Electronic Health Records for Dementia Care Research in 2026: What the Findings Mean for People With Mild Cognitive Impairment
- Implementation-Ready Dementia Interventions in the 2026 NIA Report: Questions People With Mild Cognitive Impairment Can Ask About the Research
